{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:01:44Z","timestamp":1789542104559,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s13555-020-00370-2","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T14:02:51Z","timestamp":1586354571000},"page":"387-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review"],"prefix":"10.1007","volume":"10","author":[{"given":"Joanna","family":"Nowaczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"issue":"2","key":"370_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","volume":"46","author":"D Wasserman","year":"2007","unstructured":"Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46(2):121\u201331.","journal-title":"Int J Dermatol"},{"issue":"5","key":"370_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4103\/0378-6323.116725","volume":"79","author":"KA Seetharam","year":"2013","unstructured":"Seetharam KA. Alopecia areata: an update. Indian J Dermatol Venereol Leprol. 2013;79(5):563\u201375.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"370_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1749-6632.2002.tb04229.x","volume":"966","author":"IJ Elenkov","year":"2002","unstructured":"Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci. 2002;966:290\u2013303.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"370_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1034\/j.1600-0625.2001.100605.x","volume":"10","author":"KJ McElwee","year":"2001","unstructured":"McElwee KJ, Silva K, Beamer WG, King LE Jr, Sundberg JP. Melanocyte and gonad activity as potential severity modifying factors in C3H\/HeJ mouse alopecia areata. Exp Dermatol. 2001;10(6):420\u20139.","journal-title":"Exp Dermatol"},{"issue":"1","key":"370_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaad.2008.02.005","volume":"59","author":"TA Rodriguez","year":"2008","unstructured":"Rodriguez TA, Duvic M, National Alopecia Areata Registry. Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis. J Am Acad Dermatol. 2008;59(1):137\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"370_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1529-8019.2011.01411.x","volume":"24","author":"L Petukhova","year":"2011","unstructured":"Petukhova L, Cabral RM, MacKay-Wiggan J, Clynes R, Christiano AM. The genetics of alopecia areata: what\u2019s new and how will it help our patients? Dermatol Ther. 2011;24(3):326\u201336.","journal-title":"Dermatol Ther"},{"issue":"2","key":"370_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update. Part II. Treatment. J Am Acad Dermatol. 2010;62(2):191\u2013202.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"370_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1529-8019.2011.01416.x","volume":"24","author":"E Wang","year":"2011","unstructured":"Wang E, McElwee KJ. Etiopathogenesis of alopecia areata: why do our patients get it? Dermatol Ther. 2011;24(3):337\u201347.","journal-title":"Dermatol Ther"},{"issue":"4","key":"370_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jaad.2009.04.031","volume":"61","author":"N Barahmani","year":"2009","unstructured":"Barahmani N, Schabath MB, Duvic M, National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581\u201391.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"370_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jssdds.2013.05.004","volume":"17","author":"SS Amin","year":"2013","unstructured":"Amin SS, Sachdeva S. Alopecia areata: a review. J Saudi Soc Dermatol Dermatol Surg. 2013;17(2):37\u201345.","journal-title":"J Saudi Soc Dermatol Dermatol Surg"},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"c3671","DOI":"10.1136\/bmj.c3671","volume":"341","author":"MJ Harries","year":"2010","unstructured":"Harries MJ, Sun J, Paus R, King LE Jr. Management of alopecia areata. BMJ. 2010;341:c3671.","journal-title":"BMJ"},{"issue":"7","key":"370_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11136-015-1208-z","volume":"25","author":"F Rencz","year":"2016","unstructured":"Rencz F, Baji P, Gulacsi L, et al. Discrepancies between the Dermatology Life Quality Index and utility scores. Qual Life Res. 2016;25(7):1687\u201396.","journal-title":"Qual Life Res"},{"issue":"1","key":"370_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jaad.2018.06.064","volume":"80","author":"K Phan","year":"2019","unstructured":"Phan K, Ramachandran V, Sebaratnam DF. Methotrexate for alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(1):120\u20137.e2.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"370_CR14","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.15489","volume":"33","author":"K Phan","year":"2019","unstructured":"Phan K, Sebaratnam DF. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(5):850\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10169","key":"370_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","volume":"393","author":"A Gilhar","year":"2019","unstructured":"Gilhar A, Keren A, Paus R. JAK inhibitors and alopecia areata. Lancet. 2019;393(10169):318\u20139.","journal-title":"Lancet"},{"issue":"1","key":"370_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/0974-7753.66911","volume":"2","author":"G Singh","year":"2010","unstructured":"Singh G, Lavanya M. Topical immunotherapy in alopecia areata. Int J Trichol. 2010;2(1):36\u20139.","journal-title":"Int J Trichol"},{"issue":"4","key":"370_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4103\/0019-5154.113954","volume":"58","author":"A Ohtsuki","year":"2013","unstructured":"Ohtsuki A, Hasegawa T, Komiyama E, Takagi A, Kawasaki J, Ikeda S. 308-nm excimer lamp for the treatment of alopecia areata: clinical trial on 16 cases. Indian J Dermatol. 2013;58(4):326.","journal-title":"Indian J Dermatol"},{"issue":"6","key":"370_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","volume":"63","author":"KT Amor","year":"2010","unstructured":"Amor KT, Ryan C, Menter A. The use of cyclosporine in dermatology: part I. J Am Acad Dermatol. 2010;63(6):925\u201346.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"370_CR19","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1038\/jidsymp.2013.14","volume":"16","author":"J Shapiro","year":"2013","unstructured":"Shapiro J. Current treatment of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S42\u20134.","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"370_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/bjd.17587","volume":"180","author":"J Berth-Jones","year":"2019","unstructured":"Berth-Jones J, Exton LS, Ladoyanni E, et al. British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018. Br J Dermatol. 2019;180(6):1312\u201338.","journal-title":"Br J Dermatol"},{"issue":"10","key":"370_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"370_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"370_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.5021\/ad.2016.28.5.569","volume":"28","author":"YH Jang","year":"2016","unstructured":"Jang YH, Kim SL, Lee KC, et al. A comparative study of oral cyclosporine\u00a0and betamethasone minipulse therapy in the treatment of alopecia areata. Ann Dermatol. 2016;28(5):569\u201374.","journal-title":"Ann Dermatol"},{"issue":"4","key":"370_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/09546630701846095","volume":"19","author":"BJ Kim","year":"2008","unstructured":"Kim BJ, Uk Min S, Park KY, et al. Combination therapy of cyclosporine\u00a0and methylprednisolone on severe alopecia areata. J Dermatol Treat. 2008;19(4):216\u201320.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"370_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5021\/ad.2008.20.4.172","volume":"20","author":"D Lee","year":"2008","unstructured":"Lee D, Oh DJ, Kim JW, et al. Treatment of severe alopecia areata: combination therapy using systemic cyclosporine\u00a0A with low dose corticosteroids. Ann Dermatol. 2008;20(4):172\u20138.","journal-title":"Ann Dermatol"},{"issue":"6","key":"370_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.5021\/ad.2015.27.6.676","volume":"27","author":"IK Yeo","year":"2015","unstructured":"Yeo IK, Ko EJ, No YA, et al. Comparison of high-dose corticosteroid pulse therapy and combination therapy using oral cyclosporine with low-dose corticosteroid in severe alopecia areata. Ann Dermatol. 2015;27(6):676\u201381.","journal-title":"Ann Dermatol"},{"issue":"1","key":"370_CR27","first-page":"90","volume":"11","author":"M Shaheedi-Dadras","year":"2008","unstructured":"Shaheedi-Dadras M, Karami A, Mollaei M, Moravej T, Malekzad F. The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis. Arch Iran Med. 2008;11(1):90\u20133.","journal-title":"Arch Iran Med"},{"issue":"1","key":"370_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000018184","volume":"199","author":"J Ferrando","year":"1999","unstructured":"Ferrando J, Grimalt R. Partial response of severe alopecia areata to cyclosporine\u00a0A. Dermatology. 1999;199(1):67\u20139.","journal-title":"Dermatology"},{"issue":"1","key":"370_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0190-9622(97)70342-6","volume":"36","author":"J Shapiro","year":"1997","unstructured":"Shapiro J, Lui H, Tron V, Ho V. Systemic cyclosporine\u00a0and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol. 1997;36(1):114\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"370_CR30","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018."},{"issue":"1","key":"370_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0974-7753.51913","volume":"1","author":"JR Lee","year":"2009","unstructured":"Lee JR, Choi SY, Han GS. The combination therapy of cyclosporine\u00a0and methylprednisolone on severe alopecia areata: 3-year follow-up study. Int J Trichol. 2009;1(1):1.","journal-title":"Int J Trichol"},{"issue":"5","key":"370_CR32","first-page":"1392","volume":"133","author":"A Gadzhigoroeva","year":"2013","unstructured":"Gadzhigoroeva A. Optimization of severe forms\u2019 treatment of alopecia areata using corticosteroids. J Investig Dermatol. 2013;133(5):1392.","journal-title":"J Investig Dermatol"},{"issue":"2 I","key":"370_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0190-9622(90)70032-D","volume":"22","author":"AK Gupta","year":"1990","unstructured":"Gupta AK, Ellis CN, Cooper KD, et al. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol. 1990;22(2 I):242\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"370_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaad.2003.09.032","volume":"51","author":"EA Olsen","year":"2004","unstructured":"Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines-Part II. J Am Acad Dermatol. 2004;51(3):448\u201351.","journal-title":"J Am Acad Dermatol"},{"key":"370_CR35","first-page":"56","volume":"60","author":"V Lai","year":"2019","unstructured":"Lai V, Chen G, Gin D, Sinclair R. Cyclosporin for moderate to severe alopecia areata: a double-blind, randomised, placebo-controlled clinical trial of efficacy and safety. Australas J Dermatol. 2019;60:56.","journal-title":"Australas J Dermatol"},{"issue":"7","key":"370_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-4362.1992.tb02706.x","volume":"31","author":"H Teshima","year":"1992","unstructured":"Teshima H, Urabe A, Irie M, Nakagawa T, Nakayama J, Hori Y. Alopecia universalis treated with oral cyclosporine\u00a0A and prednisolone: immunologic studies. Int J Dermatol. 1992;31(7):513\u20136.","journal-title":"Int J Dermatol"},{"issue":"7","key":"370_CR37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1345\/aph.1K628","volume":"42","author":"S Lam","year":"2008","unstructured":"Lam S, Partovi N, Ting LS, Ensom MH. Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction? Ann Pharmacother. 2008;42(7):1037\u201347.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"370_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/15569527.2013.839997","volume":"33","author":"G A\u00e7\u0131kg\u00f6z","year":"2014","unstructured":"A\u00e7\u0131kg\u00f6z G, Caliskan E, Tunca M, Yeniay Y, Akar A. The effect of oral cyclosporine in the treatment of severe alopecia areata. Cutan Ocul Toxicol. 2014;33(3):247\u201352.","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"370_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1468-3083.1996.tb00622.x","volume":"7","author":"A Constantopoulos","year":"1996","unstructured":"Constantopoulos A, Tsoumacas C, Tsivitanidou T. Cyclosporine in severe alopecia areata in children. J Eur Acad Dermatol Venereol. 1996;7(2):190\u20132.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00370-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-020-00370-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00370-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:20:48Z","timestamp":1710771648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-020-00370-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00370-2","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}